ID   SHC1_RAT                Reviewed;         469 AA.
AC   Q5M824;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 1.
DT   24-JUL-2024, entry version 137.
DE   RecName: Full=SHC-transforming protein 1;
DE   AltName: Full=Src homology 2 domain-containing-transforming protein C1;
DE            Short=SH2 domain protein C1;
GN   Name=Shc1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PHOSPHORYLATION.
RC   TISSUE=Brain;
RX   PubMed=7544443; DOI=10.1038/376737a0;
RA   Lev S., Moreno H., Martinez R., Canoll P., Peles E., Musacchio J.M.,
RA   Plowman G.D., Rudy B., Schlessinger J.;
RT   "Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion
RT   channel and MAP kinase functions.";
RL   Nature 376:737-745(1995).
RN   [3]
RP   PHOSPHORYLATION, AND INTERACTION WITH FLT4.
RX   PubMed=7675451;
RA   Fournier E., Dubreuil P., Birnbaum D., Borg J.P.;
RT   "Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming
RT   capacity of the FLT4 receptor.";
RL   Oncogene 11:921-931(1995).
RN   [4]
RP   INTERACTION WITH NTRK2.
RX   PubMed=9582017; DOI=10.1038/sj.onc.1201688;
RA   McCarty J.H., Feinstein S.C.;
RT   "Activation loop tyrosines contribute varying roles to TrkB
RT   autophosphorylation and signal transduction.";
RL   Oncogene 16:1691-1700(1998).
RN   [5]
RP   INTERACTION WITH CEACAM1.
RX   PubMed=11694516; DOI=10.1074/jbc.m108415200;
RA   Poy M.N., Ruch R.J., Fernstrom M.A., Okabayashi Y., Najjar S.M.;
RT   "Shc and CEACAM1 interact to regulate the mitogenic action of insulin.";
RL   J. Biol. Chem. 277:1076-1084(2002).
RN   [6]
RP   INTERACTION WITH DDR2.
RX   PubMed=16186108; DOI=10.1074/jbc.m506921200;
RA   Yang K., Kim J.H., Kim H.J., Park I.S., Kim I.Y., Yang B.S.;
RT   "Tyrosine 740 phosphorylation of discoidin domain receptor 2 by Src
RT   stimulates intramolecular autophosphorylation and Shc signaling complex
RT   formation.";
RL   J. Biol. Chem. 280:39058-39066(2005).
CC   -!- FUNCTION: Signaling adapter that couples activated growth factor
CC       receptors to signaling pathways. Participates in a signaling cascade
CC       initiated by activated KIT and KITLG/SCF. Participates in signaling
CC       downstream of the angiopoietin receptor TEK/TIE2, and plays a role in
CC       the regulation of endothelial cell migration and sprouting angiogenesis
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with CPNE3; this interaction may mediate the binding
CC       of CPNE3 with ERBB2 (By similarity). Interacts with the NPXY motif of
CC       tyrosine-phosphorylated IGF1R and INSR in vitro via the PID domain.
CC       Once activated, binds to GRB2. Interacts with tyrosine-phosphorylated
CC       CD3T and DDR2. Interacts with the N-terminal region of APS. Interacts
CC       with phosphorylated LRP1 and IRS4. Interacts with INPP5D/SHIP1 and
CC       INPPL1/SHIP2. Interacts with ALK, GAB2, GRB7 and KIT. Interacts with
CC       PTPN6/SHP (tyrosine phosphorylated). Identified in a complex containing
CC       FGFR4, NCAM1, CDH2, PLCG1, FRS2A, SRC, SHC1, GAP43 and CTTN. Interacts
CC       with EPHB1 and GRB2; activates the MAPK/ERK cascade to regulate cell
CC       migration. Interacts with PDGFRB (tyrosine-phosphorylated). Interacts
CC       with ERBB4. Interacts with TEK/TIE2 (tyrosine-phosphorylated).
CC       Interacts with PTK2/FAK1 (By similarity). Interacts with FLT4
CC       (tyrosine-phosphorylated). Interacts with the Trk receptors NTRK1,
CC       NTRK2 and NTRK3; in a phosphotyrosine-dependent manner. Interacts with
CC       CEACAM1; this interaction is CEACAM1-phosphorylation-dependent and
CC       mediates interaction with EGFR or INSR resulting in decrease coupling
CC       of SHC1 to the MAPK3/ERK1-MAPK1/ERK2 pathway (By similarity)
CC       (PubMed:11694516). Interacts (via PID domain) with PEAK1 (when
CC       phosphorylated) (By similarity). Found in a complex with PPP1CA,
CC       PPP1CC, SHC1 and PEAK1 (By similarity). {ECO:0000250|UniProtKB:P29353,
CC       ECO:0000250|UniProtKB:P98083, ECO:0000269|PubMed:11694516,
CC       ECO:0000269|PubMed:16186108, ECO:0000269|PubMed:7675451,
CC       ECO:0000269|PubMed:9582017}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell junction, focal
CC       adhesion {ECO:0000250|UniProtKB:P29353}.
CC   -!- PTM: Phosphorylated by activated epidermal growth factor receptor.
CC       Phosphorylated in response to KIT signaling. Tyrosine phosphorylated in
CC       response to FLT3 signaling and by ligand-activated ALK. Tyrosine
CC       phosphorylated by TEK/TIE2 (By similarity). Tyrosine phosphorylated by
CC       ligand-activated PDGFRB (By similarity). May be tyrosine phosphorylated
CC       by activated PTK2/FAK1 (By similarity). Dephosphorylation by PTPN2 may
CC       regulate interaction with GRB2 (By similarity). Phosphorylated in
CC       response to FLT4 signaling. Tyrosine phosphorylated by activated
CC       PTK2B/PYK2. {ECO:0000250, ECO:0000269|PubMed:7544443,
CC       ECO:0000269|PubMed:7675451}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC088298; AAH88298.1; -; mRNA.
DR   RefSeq; NP_445969.2; NM_053517.2.
DR   AlphaFoldDB; Q5M824; -.
DR   BMRB; Q5M824; -.
DR   SMR; Q5M824; -.
DR   BioGRID; 250090; 9.
DR   CORUM; Q5M824; -.
DR   IntAct; Q5M824; 7.
DR   MINT; Q5M824; -.
DR   STRING; 10116.ENSRNOP00000028038; -.
DR   iPTMnet; Q5M824; -.
DR   jPOST; Q5M824; -.
DR   PaxDb; 10116-ENSRNOP00000028038; -.
DR   PeptideAtlas; Q5M824; -.
DR   GeneID; 85385; -.
DR   KEGG; rno:85385; -.
DR   UCSC; RGD:620446; rat.
DR   AGR; RGD:620446; -.
DR   CTD; 6464; -.
DR   RGD; 620446; Shc1.
DR   eggNOG; KOG3697; Eukaryota.
DR   InParanoid; Q5M824; -.
DR   OrthoDB; 2903566at2759; -.
DR   PhylomeDB; Q5M824; -.
DR   Reactome; R-RNO-1250196; SHC1 events in ERBB2 signaling.
DR   Reactome; R-RNO-1250347; SHC1 events in ERBB4 signaling.
DR   Reactome; R-RNO-167044; Signalling to RAS.
DR   Reactome; R-RNO-180336; SHC1 events in EGFR signaling.
DR   Reactome; R-RNO-201556; Signaling by ALK.
DR   Reactome; R-RNO-210993; Tie2 Signaling.
DR   Reactome; R-RNO-2424491; DAP12 signaling.
DR   Reactome; R-RNO-2428933; SHC-related events triggered by IGF1R.
DR   Reactome; R-RNO-2730905; Role of LAT2/NTAL/LAB on calcium mobilization.
DR   Reactome; R-RNO-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-RNO-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-RNO-354192; Integrin signaling.
DR   Reactome; R-RNO-512988; Interleukin-3, Interleukin-5 and GM-CSF signaling.
DR   Reactome; R-RNO-5654688; SHC-mediated cascade:FGFR1.
DR   Reactome; R-RNO-5654699; SHC-mediated cascade:FGFR2.
DR   Reactome; R-RNO-5654704; SHC-mediated cascade:FGFR3.
DR   Reactome; R-RNO-5654719; SHC-mediated cascade:FGFR4.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-74749; Signal attenuation.
DR   Reactome; R-RNO-74751; Insulin receptor signalling cascade.
DR   Reactome; R-RNO-8851805; MET activates RAS signaling.
DR   Reactome; R-RNO-8853659; RET signaling.
DR   Reactome; R-RNO-8983432; Interleukin-15 signaling.
DR   Reactome; R-RNO-9009391; Extra-nuclear estrogen signaling.
DR   Reactome; R-RNO-9020558; Interleukin-2 signaling.
DR   Reactome; R-RNO-9027284; Erythropoietin activates RAS.
DR   Reactome; R-RNO-912526; Interleukin receptor SHC signaling.
DR   Reactome; R-RNO-9634597; GPER1 signaling.
DR   Reactome; R-RNO-9674555; Signaling by CSF3 (G-CSF).
DR   Reactome; R-RNO-9842663; Signaling by LTK.
DR   PRO; PR:Q5M824; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0010008; C:endosome membrane; IDA:RGD.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0070435; C:Shc-EGFR complex; IDA:BHF-UCL.
DR   GO; GO:0046875; F:ephrin receptor binding; ISO:RGD.
DR   GO; GO:0048408; F:epidermal growth factor binding; ISO:RGD.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0005158; F:insulin receptor binding; ISO:RGD.
DR   GO; GO:0005159; F:insulin-like growth factor receptor binding; ISO:RGD.
DR   GO; GO:0005168; F:neurotrophin TRKA receptor binding; ISO:RGD.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:RGD.
DR   GO; GO:0001784; F:phosphotyrosine residue binding; IPI:RGD.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB.
DR   GO; GO:0005068; F:transmembrane receptor protein tyrosine kinase adaptor activity; ISO:RGD.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IMP:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISO:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; ISO:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0042742; P:defense response to bacterium; ISO:RGD.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0048009; P:insulin-like growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; IMP:RGD.
DR   GO; GO:0031175; P:neuron projection development; IMP:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IMP:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; IMP:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0006940; P:regulation of smooth muscle contraction; IMP:RGD.
DR   GO; GO:1990839; P:response to endothelin; IMP:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0032868; P:response to insulin; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   CDD; cd01209; PTB_Shc; 1.
DR   CDD; cd09925; SH2_SHC; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 1.
DR   InterPro; IPR051235; CEP152/SHC-Transforming.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR006019; PID_Shc-like.
DR   InterPro; IPR006020; PTB/PI_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR035676; SHC_SH2.
DR   PANTHER; PTHR10337; SHC TRANSFORMING PROTEIN; 1.
DR   PANTHER; PTHR10337:SF2; SHC-TRANSFORMING PROTEIN 1; 1.
DR   Pfam; PF00640; PID; 1.
DR   Pfam; PF00017; SH2; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00629; SHCPIDOMAIN.
DR   SMART; SM00462; PTB; 1.
DR   SMART; SM00252; SH2; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF55550; SH2 domain; 1.
DR   PROSITE; PS01179; PID; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Angiogenesis; Cell junction; Cytoplasm; Growth regulation;
KW   Phosphoprotein; Reference proteome; SH2 domain.
FT   CHAIN           1..469
FT                   /note="SHC-transforming protein 1"
FT                   /id="PRO_0000327222"
FT   DOMAIN          46..229
FT                   /note="PID"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00148"
FT   DOMAIN          374..465
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   REGION          1..26
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          230..373
FT                   /note="CH1"
FT   REGION          322..344
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         29
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P29353"
FT   MOD_RES         44
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P98083"
FT   MOD_RES         239
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P29353"
FT   MOD_RES         240
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P29353"
FT   MOD_RES         313
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P29353"
FT   MOD_RES         339
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P29353"
SQ   SEQUENCE   469 AA;  51503 MW;  9BFEE9D33E07B3F9 CRC64;
     MNKLSGGGGR RTRVEGGQLG GEEWTRHGSF VNKPTRGWLH PNDKVMGPGV SYLVRYMGCV
     EVLQSMRALD FNTRTQVTRE AISLVCEAVP GAKGAMRRRK PCSRPLSSIL GRSNLKFAGM
     PITLTVSTSS LNLMAADCKQ IIANHHMQSI SFASGGDPDT AEYVAYVAKD PVNQRACHIL
     ECPEGLAQDV ISTIGQAFEL RFKQYLRNPP KLVTPHDRMA GFDGSAWDEE EEELPDHQYY
     NDFPGKEPPL GGVVDMRLRE GAARPTLPST QMPSHLGATL PIGQHVTGDH EVRKQMLPPP
     PCPGRELFDD PSYVNIQNLD KARQAGGGAG PPNPSVNGSA PRDLFDMKPF EDALRVPPAP
     QSMSMAEQLQ GESWFHGKLS RREAEALLQL NGDFLVREST TTPGQYVLTG LQSGQPKHLL
     LVDPEGVVRT KDHRFESVSH LISYHMDNHL PIISAGSELC LQQPVDRKV
//
